Key points from article :
LabGenius is a company that uses AI to design new medical antibodies.
The company's approach is to automate the antibody discovery process, from design to testing.
A machine-learning model designs antibodies to differentiate between healthy and diseased cells.
The model is trained on a dataset of known antibodies and can explore a much larger search space than human designers.
The model can design more than 700 antibodies in a single round of testing.
The antibodies are then grown and tested in the lab, and the data is fed back into the model to improve its designs.
The company has raised $28 million from investors and is beginning to partner with pharmaceutical companies.
The company believes that its approach could lead to the development of more effective and safer antibody treatments.
The company's work is still in its early stages, but it has the potential to revolutionise how new medical antibodies are developed.
